Abstract: Quantitative structure-activity relationship (QSAR) analysis of 28 quinoline-arylamidine (CQArA) hybrids against two leukemia cells, K562 and Raji, was performed. Multiple linear regression (MLR) models were obtained by genetic algorithm. The best models involved the following descriptors: radial distribution function (RDF) descriptors, GETAWAY (GEometry, Topology, and Atom-Weights AssemblY) descriptor, bond information content index, and dipole moment. The best MLR models for K562 and Raji cells demonstrated satisfactory stability in internal and external validation. Since the QSAR model for Raji cells has better predictive ability, two new highly potent CQArA analogues were proposed based on it. The QSAR models revealed important physicochemical and structural requirements for the antitumor activity: enhanced 3D molecular distribution of mass calculated at radius 11 Å from the center of molecule, a higher number of terminal electronegative atoms, extension of the molecules' central linker between quinoline and arylamidine, higher ratio of single bonds and total number of atoms, and symmetric charge distribution. Molecular docking study was applied to ensure the anticancer activity affinity to the binding site of the tyrosine-protein kinase (c-SRC). It was confirmed that the most active compound binds on the pocket between the small and large lobes of c-SRC, mostly throughout the hydrogen bonds and van der Waals interactions.
Introduction
A major problem in chemotherapeutic treatment of cancer is drug resistance. In order to overcome this problem, multiple cytotoxic drugs with different chemical structures and mechanisms of action have been employed. 1 Hybrid anticancer drugs are designed and synthesized from two or more different bioactive moieties conjugated into a single drug. Such multitarget anticancer agents have great therapeutic potential since they trigger two or more cytocidal pharmacological mechanisms of action, acting in synergy to inhibit the growth of cancer cells.
2,3
Considering their contribution in the discovery of a new anticancer therapy, the research on hybrid molecules is rapidly evolving.
Chloroquine (CQ), a 7-chloro-4-aminoquinoline, has been the mainstay of malaria chemotherapy for years. A number of other existing antimalarial agents, as well as novel derivatives of CQ, have been tested as possible cancer therapeutics. 4−9 Hydroxychloroquine (HCQ), a CQ derivative, has recently been investigated in clinical trials for cancer therapy. 10 Arylamidines exhibited broad pharmacological activities, such as antiparasitic, 11 antibacterial, 12, 13 and anticancer activity.
14 Recently, we synthesized and evaluated the antitumor activity of a new class of hybrid molecules joining these two pharmacophores, 7-chloroquinoline and arylamidine. 15 The four series of molecular hybrids contain a quinoline moiety, whereas the linkers between quinoline and arylamidine, the aryl core, and terminal amidine moiety were modified. The investigated compounds showed higher efficacy against a human chronic myelogenous leukemia cell line (K562) and lymphoblastoid cell line (Raji) than carcinoma cells. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Their activity may acquire transforming functions due to mutation(s), overexpression, and autocrine paracrine stimulation, leading to malignancy.
Selective tyrosine kinase inhibitors can block the oncogenic activation in cancer cells and can be applied as a new mode of cancer therapy. 16 Nonreceptor protein-tyrosine kinase (c-Src) is a protooncogene that plays key roles in cell morphology, motility, proliferation, and survival. 
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In order to signify the importance of structural and chemical attributes for the anticancer activity of 7-chloroquinoline-arylamidine (CQArA) hybrids and to improve further research on the mechanisms of action of these compounds against leukemia cells and also to propose new analogues with improved activity, quantitative structure-activity relationship (QSAR) analysis was performed. The interaction of CQArA hybrids and protooncogene tyrosine-protein kinase Src in silico was evaluated by molecular docking based on the binding mode of the DSA inhibitor.
Results and discussion

QSAR models
The best model obtained for anticancer activity against the K562 leukemia cell line is:
Compounds in the test set, 9, 13, 18, 20, and 25, were selected by ranking method.
For antitumor activity against the Raji leukemia cell line, the best model is:
Compounds in the test set, 1, 2, 5, 11, and 20, were selected by random method.
Structures of analyzed compounds are presented in the Scheme. Experimental and calculated logGI 50 by Eqs.
(1) and (2) are shown in Table 1 . The values of descriptors included in the models of Eqs. (1) and (2) are given in the Supplemental Information, Table S1 . The statistical results for the obtained models are presented in Table 2 .
Both models satisfy fitting criteria ( R 2 ≥ 0.60). In order to exclude the possibility that the models are overfitted, the collinearity of descriptors included in the models of Eqs. (1) and (2) Scheme. Structures of the analyzed compounds. Table 4 . Correlation matrix for the descriptors included in model (2) .
The lower values of revealed no outliers and no compounds outside of the hat value of leverage or warning leverage ( h * = 0.52), which means that all the predicted data for compounds belong to the chemical domain. Model (2) also has no outliers, except compound 22, which slightly exceeds the critical hat value of leverage. This can be explained by the fact that the applicability domain represents the "distance" of the compound from the experimental model, and compound 22 has shown exceptionally high anticancer activity against the Raji leukemia line. For that compound, prediction is not reliable and predicted values of these compounds must be used with reserve ( Figure 1b ).
Despite the difference in the predictive potential of the proposed models, the included molecular descriptors may aid in the elucidation of important physicochemical and structural requirements for the antitumor activity of CQArA hybrids. Two radial distribution function (RDF) descriptors are present in model (1) . The radial distribution function can be interpreted as the probability distribution of finding an atom in a spherical volume of a certain radius. 23 Therefore, the descriptor RDF120m included model (1) presents 3D molecular distribution of mass in a spherical volume of radius 12 Å. The molecules with the largest molecular radius and highest molecular weight have the highest values of descriptor RDF120m have (Table S1 ). According to the negative sign of RDF120m in model (1), higher values of those descriptors are favorable for the exhibition of antitumor activity. Similarly, the negative coefficient of descriptor RDF110m in model (2) implies that enhanced 3D molecular distribution of mass calculated at radius 11 Å from the specific geometrical centers of each molecule increases the antitumor potential. Figure 2 presents the 3D distribution of the mass at 11 Å from the center of the most active compound, 22. The positive regression coefficient of RDF150p in model (1) suggests that enhanced atomic polarizability at the spherical volume of radius 15 Å negatively influences the antitumor activity of CQArA compounds. The value of that descriptor is strongly influenced by the number of carbon atoms in the external part of a molecule.
Difference in values of that descriptor is mostly visible between the isopropyl and isobutyl-substituted 10 and 11 and 17 and 18, respectively (Scheme 1). Descriptor R2e + is a descriptor of R maximal autocorrelation of lag 2 weighted by Sanderson electronegativity, which belongs to the GETAWAY (GEometry, Topology, and AtomWeights AssemblY) descriptors. The given descriptor is derived from the representation of molecular structure called the influence/distance matrix, R, where the elements of the molecular influence matrix are combined with geometric interatomic distances in the molecule. 24 It takes into account local aspects of the molecule, with atomic electronegativity at topological distance 2. The most external atoms at the small interatomic space have the highest influences on the value of R-GETAWAY descriptors. Therefore, molecules with a higher number of terminal electronegative atoms (nitrogen) have higher values of R2e + (Table S1) (Table S1 ) and enhanced antitumor activities against the growth of K562 cells. As we pointed out previously, extension of the molecules' central linker can improve the antiproliferative effect since it enhances the flexibility and adaptability of the molecular conformation when binding to DNA. The results of QSAR analysis could help to discover new compounds with possibly great antitumor potential. We propose two molecules as new potential anticancer agents. Activity against Raji leukemia cells has been predicted by means of model (2) (Figure 4 ). Antitumor activities of the proposed compounds are logGI 50calc = 0.02 and -0.29 for 29 and 30, respectively. Compared to compound 15, proposed molecule 29 has an extended central linker between 7-CQ and arylamidine by one -CH 2 -group, which resulted in enhancement of the calculated activity. Involving the second nitrile group on the benzimidazole, the polar charge is distributed more symmetrically, which makes a molecule less polar and potentially extremely powerful. 
Molecular docking study
Molecular docking studies provide virtual screening of different molecules as potential ligands to predict their ability to interact with given target candidates. Potential ligand molecules are ranked using various scoring functions. 25 For the present study we have chosen protooncogene tyrosine-protein kinase c-Src (PDB ID: 3G6H)
as a target molecule. Compounds were ranked by total energy of predicted pose in the binding site. Docking results for the seven best ranking CQArA compounds are tabulated in Table 5 . Results were compared with docking results of bonded ligand pyridinyl triazine (DSA1, PDB ID: G6H). is also the most active compound (Table 1) . After compound 22, compound 29 appears in the ranking, followed by compound 30, both proposed by the QSAR study. Their high energy-based scoring functions confirm their possible high antitumor activity predicted by QSAR.
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The binding site of tyrosine kinase was defined according to the inhibitor DSA1. 19 The structure of the Src kinase domain consists of a small amino-terminal (N) lobe (residues 267-337) and large carboxyl-terminal (C) lobe (residues 341-520) connected by a "hinge". The N lobe contains antiparallel β -sheet structures and Our results are consistent with the previous results of a docking study of azaacridine derivatives, 27 which revealed that the amido moiety formed two hydrogen bonds with Glu-310 and Asp-404 in the DFG out-pocket of c-SRC. This is in agreement with previously QSAR findings that the 2-aminoethanol linker (compounds 15-28) between quinoline and arylamidine enhanced anticancer activity compared to the other compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) without an amino group in the central linker.
Conclusions
In the present work, the QSAR analysis of anticancer activities of 7-chloroquinoline-arylamidine hybrids against two leukemia cell lines, Raji and K562, has been performed. The best obtained QSAR models revealed that important physicochemical and structural requirements for the anticancer activity of CQArA hybrids are enhanced 3D molecular distribution of mass calculated at radius 11 Å from the geometrical center of the molecule; the higher number of terminal electronegative atoms; extension of the molecules' central linker between the quinoline and arylamidine parts, which should contain an amino group; a higher ratio of single bonds and total number of atoms; and symmetric charge distribution that leads to the less polar molecule. According to the predictive model for anticancer activity against Raji cells, two new potent quinolone-arylamidine analogues were proposed.
Molecular docking has confirmed the importance of the terminal nitrile group and amino groups from the 2-aminoethanol linker for enhanced binding affinity toward tyrosine kinase. Our study suggests that CQArA hybrids could be developed as novel tyrosine kinase inhibitors in the treatment of leukemia. 
Experimental
Dataset
The synthesis and evaluation of anticancer activity derivatives were described in our previous study. 15 Structures of the analyzed compounds are presented in the Scheme. Anticancer activities, expressed as the concentration achieving 50% cell growth inhibition (GI 50 /µ M) against leukemia cell lines (Raji and K562), were converted in the form of the logarithm (logGI 50 ) and are presented in Table 1 . For the inactive compounds whose GI 50
values were estimated as 100, logGI 50 was set to 2.
QSAR
Descriptor calculation
The 3D structures of 28 molecules were optimized applying Avogadro 1.2.0 (University of Pittsburgh, Pittsburgh, PA, USA) using the molecular mechanics force field (MM +). 28 Subsequently, all the structures were submitted to geometry optimization using the semiempirical PM3 method. 29 Two sets of descriptors were generated us- 
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After reducing the number of calculated descriptors, the number of remaining descriptors in the pool was 492.
Regression analysis and validation of models
Two algorithms were used for creating the training and test sets (20%), a random method and a ranking method, using QSARINS. The best QSAR models were obtained with a genetic algorithm (GA) using QSARINS. parameters: root-mean-square error of the training set (RMSE tr ) , root-mean-square error of the training set determined through cross-validated LOO method (RMSE cv ), concordance correlation coefficient of the training set (CCC tr ), test set using LOO cross-validation (CCC cv ) , mean absolute error of the training set (MAE tr ) , mean absolute error of the internal validation set (MAE cv ) , and predictive residual sum of squares determined through cross-validated LOO method (PRESS cv ) in the training set.
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Investigation of the applicability domain 22 of prediction models was performed by leverage plot (Williams plots) using QSARINS.
Molecular docking
The molecular docking of the compounds (1-30) was performed with i GEMDOCK (BioXGEM, Taiwan).
Crystal coordinates of the c-Src (PDB ID: 3G6H) in the complex with DSA compound (PDB ID: G6H) were downloaded from the Protein Data Bank (PDB, https://www.rcsb.org/). In the first step, the structure of c-Src was prepared, including the removal of water molecules and optimized protein structure using BIOVIA Discovery 2). Each compound in the library was docked into the binding site and protein-compound interaction profiles of electrostatic (Elec), hydrogen-bonding (Hbond), and vdW interactions were generated. Finally, compounds were ranked by combining the pharmacological interactions and energy-based scoring function. Energy-based scoring function or total energy (E) is: E = vdW + Hbond + Elec. Table S1 . Values of the most relevant descriptors in QSAR models (1) and (2) with predicted values of values (logGI50calc) calculated by QSAR models (1) and (2) for 30 CQArA hybrids against leukemia cell lines K562 and Raji, respectively.
